Alzheimer's may worsen COVID-19 outcomes via olfactory mucosa changes

A new study identifies alterations in the transcriptomic signatures in human olfactory mucosal cells of individuals with Alzheimer's disease following SARS-CoV-2 infection, potentially contributing to exacerbated COVID-19 outcomes.

Related Keywords

Kuopio ,Norra Savolax ,Finland ,Helsinki ,Eteläuomen Läi ,Katja Kanninen ,Ali Shahbaz ,University Of Eastern Finland ,University Of Helsinki ,Kuopio University Hospital ,Academy Of Finland ,Eastern Finland ,Kuopio University ,Professor Katja Kanninen ,Alzheimer 39s Disease ,Covid 19 ,Gene ,Ranscription ,Rain ,Research ,Cars ,Ars Cov 2 ,Virus ,